CN112869744B - Auxiliary diagnosis method, system and storage medium for schizophrenia - Google Patents
Auxiliary diagnosis method, system and storage medium for schizophrenia Download PDFInfo
- Publication number
- CN112869744B CN112869744B CN202110075057.8A CN202110075057A CN112869744B CN 112869744 B CN112869744 B CN 112869744B CN 202110075057 A CN202110075057 A CN 202110075057A CN 112869744 B CN112869744 B CN 112869744B
- Authority
- CN
- China
- Prior art keywords
- samples
- schizophrenia
- saccade
- calculation process
- eye tracking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0016—Operational features thereof
- A61B3/0025—Operational features thereof characterised by electronic signal processing, e.g. eye models
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/113—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
- A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Artificial Intelligence (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Pathology (AREA)
- Mathematical Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Fuzzy Systems (AREA)
- Evolutionary Computation (AREA)
- Ophthalmology & Optometry (AREA)
- Educational Technology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Social Psychology (AREA)
- Psychology (AREA)
- Human Computer Interaction (AREA)
- Eye Examination Apparatus (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及精神病诊断技术领域,具体涉及一种精神分裂症辅助诊断方法、系统和存储介质。The present invention relates to the technical field of mental illness diagnosis, and in particular to a schizophrenia auxiliary diagnosis method, system and storage medium.
背景技术Background technique
精神分裂症是一种极其复杂多基因与遗传性状相关的临床症候群,具有发病年龄早、病程长、功能损害严重、社会危害大的特点。目前,该疾病的诊断主要依靠医生临床问诊来判断,缺乏良好的生物学指标,因此存在误诊率高、病患疗程延误等情况。Schizophrenia is an extremely complex clinical syndrome associated with multiple genes and genetic traits, with the characteristics of early onset, long course, severe functional impairment, and great social harm. At present, the diagnosis of this disease mainly relies on clinical interviews by doctors, lacking good biological indicators, resulting in a high misdiagnosis rate and delayed treatment for patients.
近年来,基于虹膜反射和视频图像捕捉的眼动追踪技术日趋成熟,眼动数据的精度和采集的便捷程度逐渐升高。眼动的脑机制研究表明,完整的眼动过程既需要感觉运动转换功能也需要认知功能引导。感觉运动转换功能将视网膜接收到的视觉信号转化为眼球运动,而更高级的眼动过程如抑制性眼动控制、对目标运动速度的预测等,需要大脑启动认知功能进行调控。因此,眼球活动指标可以作为探索人类大脑皮层和皮层下相关高级认知过程的行为学测量指标。In recent years, eye tracking technology based on iris reflection and video image capture has become increasingly mature, and the accuracy of eye movement data and the convenience of collection have gradually increased. Studies on the brain mechanism of eye movement have shown that the complete eye movement process requires both sensorimotor conversion function and cognitive function guidance. The sensorimotor conversion function converts the visual signals received by the retina into eye movements, while more advanced eye movement processes such as inhibitory eye movement control and prediction of target movement speed require the brain to activate cognitive functions for regulation. Therefore, eye movement indicators can be used as behavioral measurement indicators to explore the human cerebral cortex and subcortical related advanced cognitive processes.
发明内容Summary of the invention
本发明的目在于针对已有精神分裂症的异常眼动行为模式,提出一系列具有显著异常的眼动指标,并将这些指标作为特征,利用机器学习方法对被试的精神分裂症患病风险进行预测。The purpose of the present invention is to propose a series of eye movement indicators with significant abnormalities for the abnormal eye movement behavior patterns of existing schizophrenia, and use these indicators as features to predict the risk of schizophrenia in the subjects using machine learning methods.
为了达到上述目的,本发明一方面提供一种精神分裂症辅助诊断方法,其特征在于,其具体步骤如下:In order to achieve the above object, the present invention provides a method for auxiliary diagnosis of schizophrenia, characterized in that the specific steps are as follows:
S1,对志愿者和患者进行自由视图实验,采集眼动追踪数据,建立数据库;S1, conduct free view experiments on volunteers and patients, collect eye tracking data, and establish a database;
S2,基于特征计算公式建立样本特征矩阵;S2, establish a sample feature matrix based on the feature calculation formula;
S3,训练支持向量机分类模型;S3, training support vector machine classification model;
S4,对受测者进行自由视图实验,采集眼动追踪数据,并计算样本特征矩阵;S4, conduct a free view experiment on the subjects, collect eye tracking data, and calculate the sample feature matrix;
S5,将受测者的样本特征矩阵输入步骤S3中训练好的分类模型,根据分类结果计算患病风险,输出诊断结论。S5, input the sample feature matrix of the subject into the classification model trained in step S3, calculate the disease risk according to the classification result, and output the diagnosis conclusion.
进一步的,所述步骤S1中,还包括:Furthermore, the step S1 further includes:
S101,采用眼动追踪设备记录受试者的眼动追踪数据,所述眼动追踪数据包括眼球注视位置和跳视路径;S101, using an eye tracking device to record eye tracking data of a subject, wherein the eye tracking data includes eye gaze position and saccadic path;
S102,将受试者的序号与图片名称作为主键建立关系型数据库,所述数据库中每一条记录作为样本均包括与主键相对应的眼动追踪数据。S102, establishing a relational database using the subject's serial number and the picture name as primary keys, wherein each record in the database as a sample includes eye tracking data corresponding to the primary key.
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S201,计算平均视跳速度其计算过程为:S201, calculate the average visual saccade velocity The calculation process is:
其中,n表示跳视次数,Ampi表示第i次跳视的跳视强度,ti表示第i次跳视的持续时间,两者相除得到该次跳视的速度,再求n次跳视速度的平均值 Where n is the number of saccades, Amp i is the intensity of the saccade of the i-th saccade, and ti is the duration of the i-th saccade. The speed of the saccade is obtained by dividing the two, and then the average speed of n saccades is calculated.
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S202,计算瞳孔动态范围,其计算过程为:S202, calculating the pupil dynamic range, the calculation process is:
其中,dmax和dmin分别表示最大瞳孔直径和最小瞳孔直径,表示瞳孔平均直径。Where d max and d min represent the maximum pupil diameter and the minimum pupil diameter, respectively. Represents the average pupil diameter.
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S203,计算瞳孔最大均值比MMRPS,其计算过程为:S203, calculating the maximum mean pupil ratio MMRPS, the calculation process is:
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S204,计算注视点偏度SF,其计算过程为:S204, calculate the fixation point skewness SF, the calculation process is:
其中,x0和y0分别是图像几何中心的横纵坐标,xi和yi表示第i个注视点的横纵坐标,n为注视点个数。Among them, x0 and y0 are the horizontal and vertical coordinates of the geometric center of the image, xi and yi represent the horizontal and vertical coordinates of the i-th fixation point, and n is the number of fixation points.
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S205,计算有效观察时间,其计算过程为:S205, calculating the effective observation time, the calculation process is:
其中,n和m分别代表注视点个数和跳视次数,表示第i个注视点的注视持续时间,/>表示第j次跳视的跳视持续时间,计算结果为有效观察时间,记为tvalid。Among them, n and m represent the number of fixations and the number of saccades, respectively. represents the fixation duration of the ith fixation point, /> represents the saccade duration of the j-th saccade, and the calculated result is the effective observation time, denoted as t valid .
进一步的,所述步骤S2中,还包括:Furthermore, the step S2 further includes:
S206,将计算出的五个特征值与对应的受试者序号及图片名称进行合并,组成样本特征矩阵,所述样本特征矩阵的维数为N×5,N为样本总数。S206, merging the calculated five eigenvalues with the corresponding subject serial numbers and picture names to form a sample feature matrix, wherein the dimension of the sample feature matrix is N×5, where N is the total number of samples.
进一步的,所述步骤S3中,还包括:Furthermore, the step S3 further includes:
S301,将数据库中患者和志愿者的样本分别作为正样本和负样本,训练支持向量机模型;S301, using samples of patients and volunteers in the database as positive samples and negative samples respectively, to train a support vector machine model;
S302,选用高斯径向基函数核,将低维特征映射到高维特征空间,计算两个样本之间的距离;S302, selecting a Gaussian radial basis function kernel, mapping the low-dimensional features to a high-dimensional feature space, and calculating the distance between the two samples;
S303,采用顺序最小化优化方法对支持向量机进行训练,其损失函数设定为平均误差函数。S303, using a sequential minimization optimization method to train the support vector machine, and setting the loss function as an average error function.
进一步的,所述样本之距离的计算过程为:Furthermore, the calculation process of the distance between the samples is:
其中,x和x'分别表示两个样本的特征向量,σ是该核函数的缩放因子。Among them, x and x' represent the feature vectors of two samples respectively, and σ is the scaling factor of the kernel function.
进一步的,在所述步骤S5中,所述诊断结果的计算过程包括:Furthermore, in step S5, the calculation process of the diagnosis result includes:
S501,根据下式计算预测结果:S501, calculate the prediction result according to the following formula:
其中,p定义为分类结果中分类为正样本的数量除以总样本数量,Th为预先设定的阈值;Among them, p is defined as the number of samples classified as positive in the classification results divided by the total number of samples, and Th is a pre-set threshold;
S502,计算置信度:S502, calculate confidence:
Conf(p)=2*[sigmoid(10*|p-0.5|)-0.5]Conf(p)=2*[sigmoid(10*|p-0.5|)-0.5]
其中,sigmoid为激活函数,定义为:Among them, sigmoid is the activation function, defined as:
另一方面,本发明还提供一种精神分裂症辅助诊断系统,包括:On the other hand, the present invention also provides a schizophrenia auxiliary diagnosis system, comprising:
数据获取模块,对志愿者和患者进行自由视图实验,采集眼动追踪数据,建立数据库;The data acquisition module conducts free-view experiments on volunteers and patients, collects eye tracking data, and builds a database;
特征提取模块,基于特征计算公式建立样本特征矩阵;Feature extraction module, which establishes a sample feature matrix based on the feature calculation formula;
模型建立模块,训练支持向量机分类模型;Model building module, training support vector machine classification model;
诊断输出模块,将受测者的样本特征矩阵输入训练好的分类模型,根据分类结果计算患病风险,输出诊断结论。The diagnosis output module inputs the sample feature matrix of the subject into the trained classification model, calculates the risk of disease based on the classification results, and outputs the diagnosis conclusion.
另一方面,本发明还提供一种计算机可读存储介质,所述计算机可读存储介质存储有计算机程序,所述计算机程序包括程序指令,所述程序指令当被处理器执行时使所述处理器执行如权利要求上述方法的步骤。On the other hand, the present invention further provides a computer-readable storage medium storing a computer program, wherein the computer program includes program instructions, and when the program instructions are executed by a processor, the processor executes the steps of the method as claimed in claim 1 .
本发明具有以如下有益效果:The present invention has the following beneficial effects:
本发明基于自由视图实验收集眼动数据,具有简单易操作、人工工作量小的特点,并且基于眼动追踪数据,提出了五个具有可解释性的眼动特征,成功地将机器学习方法引入到精神分裂症诊断领域,为医生诊断精神分裂症提供了客观的量化指标和基于分类器的预测结果。The present invention collects eye movement data based on a free view experiment, which is simple and easy to operate and requires little manual work. In addition, based on the eye tracking data, five interpretable eye movement features are proposed, which successfully introduces machine learning methods into the field of schizophrenia diagnosis, and provides doctors with objective quantitative indicators and classifier-based prediction results for diagnosing schizophrenia.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
图1为本发明一种精神分裂症辅助诊断方法的方法流程图。FIG1 is a flow chart of a method for auxiliary diagnosis of schizophrenia according to the present invention.
图2为本发明预测结果的置信度函数的示意图。FIG. 2 is a schematic diagram of a confidence function of a prediction result of the present invention.
图3为本发明一种精神分裂症辅助诊断系统的系统框架图。FIG3 is a system framework diagram of a schizophrenia auxiliary diagnosis system of the present invention.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
眼球活动指标可以作为探索人类大脑皮层和皮层下相关高级认知过程的行为学测量指标。对于存在认知功能障碍的精神分裂症患者,其相对于正常人的眼动异常值可以作为表征其精神抑制状态的生物学指标。因此,可通过特定的实验范式对精神分裂症患者的眼动差异进行检测,提出一系列具有显著异常的眼动指标,并将这些指标作为特征,利用机器学习方法对被试的精神分裂症患病风险进行预测。Eye movement indicators can be used as behavioral measurement indicators to explore the higher-level cognitive processes related to the human cerebral cortex and subcortex. For schizophrenia patients with cognitive dysfunction, their eye movement abnormalities relative to normal people can be used as biological indicators to characterize their mental depression state. Therefore, the eye movement differences of schizophrenia patients can be detected through a specific experimental paradigm, and a series of eye movement indicators with significant abnormalities can be proposed. These indicators can be used as features to predict the risk of schizophrenia in the subjects using machine learning methods.
为了更好的理解上述技术方案,下面将参照附图更详细地描述本发明的示例性实施例。虽然附图中显示了本发明的示例性实施例,然而应当理解,可以以各种形式实现本发明而不应被这里阐述的实施例所限制。相反,提供这些实施例是为了能够更透彻地理解本发明,并且能够将本发明的范围完整的传达给本领域的技术人员。In order to better understand the above technical solution, exemplary embodiments of the present invention will be described in more detail below with reference to the accompanying drawings. Although exemplary embodiments of the present invention are shown in the accompanying drawings, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments described herein. On the contrary, these embodiments are provided to enable a more thorough understanding of the present invention and to fully convey the scope of the present invention to those skilled in the art.
图1是本发明实施例的一种精神分裂症辅助诊断方法的方法流程图。如图1所示,本发明实施例的一种精神分裂症辅助诊断方法的方法包括以下步骤:FIG1 is a method flow chart of a method for assisting diagnosis of schizophrenia according to an embodiment of the present invention. As shown in FIG1 , a method for assisting diagnosis of schizophrenia according to an embodiment of the present invention comprises the following steps:
S1,对志愿者和患者进行自由视图实验,采集眼动追踪数据,建立数据库。S1, conduct free view experiments on volunteers and patients, collect eye tracking data, and establish a database.
具体的,在实验过程中请每一位志愿者或患者(统称为被试)坐在实验设备前,自由地观看屏幕上出现的图片,同时,利用专业的眼动追踪设备记录其眼球注视位置和跳视路径等信息。Specifically, during the experiment, each volunteer or patient (collectively referred to as subjects) was asked to sit in front of the experimental equipment and freely watch the pictures appearing on the screen. At the same time, professional eye tracking equipment was used to record information such as their eye gaze position and saccadic path.
实验完成后,对眼动追踪数据进行处理,以“被试序号-图片名称”为主键建立关系型数据库,即每一条“被试序号-图片名称”与其对应的眼动追踪数据作为一个样本。After the experiment is completed, the eye tracking data is processed and a relational database is established with "subject number-picture name" as the primary key, that is, each "subject number-picture name" and its corresponding eye tracking data are regarded as a sample.
S2,基于特征计算公式建立样本特征矩阵。S2, establish a sample feature matrix based on the feature calculation formula.
具体的,在所述步骤S2中,还包括:Specifically, in the step S2, it also includes:
S201,计算平均视跳速度其计算过程为:S201, calculate the average visual saccade velocity The calculation process is:
其中,n表示跳视次数,Ampi表示第i次跳视的跳视强度,ti表示第i次跳视的持续时间,两者相除得到该次跳视的速度,再求n次跳视速度的平均值 Where n is the number of saccades, Amp i is the intensity of the saccade of the i-th saccade, and ti is the duration of the i-th saccade. The speed of the saccade is obtained by dividing the two, and then the average speed of n saccades is calculated.
S202,计算瞳孔动态范围,其计算过程为:S202, calculating the pupil dynamic range, the calculation process is:
其中,dmax和dmin分别表示最大瞳孔直径和最小瞳孔直径,表示瞳孔平均直径。Where d max and d min represent the maximum pupil diameter and the minimum pupil diameter, respectively. Represents the average pupil diameter.
S203,计算瞳孔最大均值比MMRPS,其计算过程为:S203, calculating the maximum mean pupil ratio MMRPS, the calculation process is:
S204,计算注视点偏度SF,其计算过程为:S204, calculate the fixation point skewness SF, the calculation process is:
其中,x0和y0分别是图像几何中心的横纵坐标,xi和yi表示第i个注视点的横纵坐标,n为注视点个数。Among them, x0 and y0 are the horizontal and vertical coordinates of the geometric center of the image, xi and yi represent the horizontal and vertical coordinates of the i-th fixation point, and n is the number of fixation points.
S205,计算有效观察时间,其计算过程为:S205, calculating the effective observation time, the calculation process is:
其中,n和m分别代表注视点个数和跳视次数,表示第i个注视点的注视持续时间,/>表示第j次跳视的跳视持续时间,计算结果为有效观察时间,记为tvalid。Among them, n and m represent the number of fixations and the number of saccades, respectively. represents the fixation duration of the ith fixation point, /> represents the saccade duration of the j-th saccade, and the calculated result is the effective observation time, denoted as t valid .
S206,将计算出的五个特征值与对应的受试者序号及图片名称进行合并,组成样本特征矩阵,所述样本特征矩阵的维数为N×5,N为样本总数。S206, merging the calculated five eigenvalues with the corresponding subject serial numbers and picture names to form a sample feature matrix, wherein the dimension of the sample feature matrix is N×5, where N is the total number of samples.
S3,训练支持向量机分类模型。S3, train the support vector machine classification model.
具体的,在步骤S3中,还包括:Specifically, in step S3, it also includes:
S301,将数据库中患者和志愿者的样本分别作为正样本和负样本,训练支持向量机模型。S301, using the samples of patients and volunteers in the database as positive samples and negative samples respectively, to train a support vector machine model.
S302,选用高斯径向基函数核,将低维特征映射到高维特征空间,计算两个样本之间的距离。S302, select a Gaussian radial basis function kernel, map the low-dimensional features to a high-dimensional feature space, and calculate the distance between the two samples.
其中,所述样本之距离的计算过程为:The calculation process of the distance between the samples is as follows:
其中,x和x'分别表示两个样本的特征向量,σ是该核函数的缩放因子。Among them, x and x' represent the feature vectors of two samples respectively, and σ is the scaling factor of the kernel function.
S303,采用顺序最小化优化方法对支持向量机进行训练,其损失函数设定为平均误差函数。S303, using a sequential minimization optimization method to train the support vector machine, and setting the loss function as an average error function.
S4,对受测者进行自由视图实验,采集眼动追踪数据,并计算样本特征矩阵.S4, conduct a free view experiment on the subjects, collect eye tracking data, and calculate the sample feature matrix.
S5,将受测者的样本特征矩阵输入步骤S3中训练好的分类模型,根据分类结果计算患病风险,输出诊断结论。S5, input the sample feature matrix of the subject into the classification model trained in step S3, calculate the disease risk according to the classification result, and output the diagnosis conclusion.
具体的,在步骤S5中,所述诊断结果的计算过程包括:Specifically, in step S5, the calculation process of the diagnosis result includes:
S501,根据下式计算预测结果:S501, calculate the prediction result according to the following formula:
其中,p定义为分类结果中分类为正样本的数量除以总样本数量,Th为预先设定的阈值。Among them, p is defined as the number of samples classified as positive in the classification results divided by the total number of samples, and Th is a pre-set threshold.
S502,计算置信度,图2为本发明预测结果的置信度函数的示意图,如图2所示,置信度的计算函数为:S502, calculate confidence. FIG2 is a schematic diagram of the confidence function of the prediction result of the present invention. As shown in FIG2, the confidence calculation function is:
Conf(p)=2*[sigmoid(10*|p-0.5|)-0.5]Conf(p)=2*[sigmoid(10*|p-0.5|)-0.5]
其中,sigmoid为激活函数,定义为:Among them, sigmoid is the activation function, defined as:
图3为本发明一种精神分裂症辅助诊断系统的系统框架图。如图3所示,本发明一种精神分裂症辅助诊断系统包括:FIG3 is a system framework diagram of a schizophrenia auxiliary diagnosis system of the present invention. As shown in FIG3, a schizophrenia auxiliary diagnosis system of the present invention includes:
数据获取模块1,对志愿者和患者进行自由视图实验,采集眼动追踪数据,建立数据库.Data acquisition module 1: Conduct free view experiments on volunteers and patients, collect eye tracking data, and establish a database.
特征提取模块2,基于特征计算公式建立样本特征矩阵.Feature extraction module 2, establishes a sample feature matrix based on the feature calculation formula.
模型建立模块3,训练支持向量机分类模型.Model building module 3, training support vector machine classification model.
诊断输出模块4,将受测者的样本特征矩阵输入训练好的分类模型,根据分类结果计算患病风险,输出诊断结论。The diagnosis output module 4 inputs the sample feature matrix of the subject into the trained classification model, calculates the disease risk according to the classification result, and outputs the diagnosis conclusion.
在本发明的另一个实施例中本发明还提供一种计算机可读存储介质,所述计算机可读存储介质存储有计算机程序,所述计算机程序包括程序指令,所述程序指令当被处理器执行时使所述处理器执行上述方法的步骤。In another embodiment of the present invention, the present invention further provides a computer-readable storage medium, wherein the computer-readable storage medium stores a computer program, wherein the computer program includes program instructions, and when the program instructions are executed by a processor, the processor executes the steps of the above method.
本发明实施例的计算机存储介质,可以采用一个或多个计算机可读的介质的任意组合。计算机可读介质可以是计算机可读信号介质或者计算机可读存储介质。计算机可读存储介质例如可以是——但不限于——电、磁、光、电磁、红外线、或半导体的系统、装置或器件,或者任意以上的组合。计算机可读存储介质的更具体的例子(非穷举的列表)包括:具有一个或多个导线的电连接、便携式计算机磁盘、硬盘、随机存取存储器(RAM)、只读存储器(ROM)、可擦式可编程只读存储器(EPROM或闪存)、光纤、便携式紧凑磁盘只读存储器(CD-ROM)、光存储器件、磁存储器件、或者上述的任意合适的组合。在本文件中,计算机可读存储介质可以是任何包含或存储程序的有形介质,该程序可以被指令执行系统、装置或者器件使用或者与其结合使用。The computer storage medium of the embodiment of the present invention can adopt any combination of one or more computer-readable media. The computer-readable medium can be a computer-readable signal medium or a computer-readable storage medium. The computer-readable storage medium can be, for example, - but not limited to - an electrical, magnetic, optical, electromagnetic, infrared, or semiconductor system, device or device, or any combination of the above. More specific examples (non-exhaustive list) of computer-readable storage media include: an electrical connection with one or more wires, a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), an optical fiber, a portable compact disk read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the above. In this document, a computer-readable storage medium can be any tangible medium containing or storing a program, which can be used by an instruction execution system, device or device or used in combination with it.
计算机可读的信号介质可以包括在基带中或者作为载波一部分传播的数据信号,其中承载了计算机可读的程序代码。这种传播的数据信号可以采用多种形式,包括但不限于电磁信号、光信号或上述的任意合适的组合。计算机可读的信号介质还可以是计算机可读存储介质以外的任何计算机可读介质,该计算机可读介质可以发送、传播或者传输用于由指令执行系统、装置或者器件使用或者与其结合使用的程序。Computer-readable signal media may include data signals propagated in baseband or as part of a carrier wave, which carry computer-readable program code. Such propagated data signals may take a variety of forms, including but not limited to electromagnetic signals, optical signals, or any suitable combination of the above. Computer-readable signal media may also be any computer-readable medium other than a computer-readable storage medium, which may send, propagate, or transmit a program for use by or in conjunction with an instruction execution system, apparatus, or device.
计算机可读介质上包含的程序代码可以用任何适当的介质传输,包括——但不限于无线、电线、光缆、RF等等,或者上述的任意合适的组合。Program code embodied on a computer readable medium may be transmitted using any appropriate medium, including but not limited to wireless, wireline, optical fiber cable, RF, etc., or any suitable combination of the foregoing.
可以以一种或多种程序设计语言或其组合来编写用于执行本发明操作的计算机程序代码,所述程序设计语言包括面向对象的程序设计语言-诸如Java、Smalltalk、C++,还包括常规的过程式程序设计语言-诸如“C”语言或类似的程序设计语言。程序代码可以完全地在用户计算机上执行、部分地在用户计算机上执行、作为一个独立的软件包执行、部分在用户计算机上部分在远程计算机上执行、或者完全在远程计算机或终端上执行。在涉及远程计算机的情形中,远程计算机可以通过任意种类的网络——包括局域网(LAN)或广域网(WAN)-连接到用户计算机,或者,可以连接到外部计算机(例如利用因特网服务提供商来通过因特网连接)。Computer program code for performing the operations of the present invention may be written in one or more programming languages or a combination thereof, including object-oriented programming languages such as Java, Smalltalk, C++, and conventional procedural programming languages such as "C" or similar programming languages. The program code may be executed entirely on the user's computer, partially on the user's computer, as a separate software package, partially on the user's computer and partially on a remote computer, or entirely on a remote computer or terminal. In the case of a remote computer, the remote computer may be connected to the user's computer through any type of network, including a local area network (LAN) or a wide area network (WAN), or may be connected to an external computer (e.g., via the Internet using an Internet service provider).
此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括至少一个该特征。在本发明的描述中,“多个”的含义是至少两个,例如两个,三个等,除非另有明确具体的限定。In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In the description of the present invention, the meaning of "plurality" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined.
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不必须针对的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
尽管上面已经示出和描述了本发明的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本发明的限制,本领域的普通技术人员在本发明的范围内可以对上述实施例进行变化、修改、替换和变型。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Although the embodiments of the present invention have been shown and described above, it is understood that the above embodiments are exemplary and cannot be understood as limiting the present invention. A person of ordinary skill in the art can change, modify, replace and modify the above embodiments within the scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110075057.8A CN112869744B (en) | 2021-01-20 | 2021-01-20 | Auxiliary diagnosis method, system and storage medium for schizophrenia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110075057.8A CN112869744B (en) | 2021-01-20 | 2021-01-20 | Auxiliary diagnosis method, system and storage medium for schizophrenia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112869744A CN112869744A (en) | 2021-06-01 |
CN112869744B true CN112869744B (en) | 2024-05-31 |
Family
ID=76050451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110075057.8A Active CN112869744B (en) | 2021-01-20 | 2021-01-20 | Auxiliary diagnosis method, system and storage medium for schizophrenia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112869744B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115444423A (en) * | 2022-10-18 | 2022-12-09 | 上海耐欣科技有限公司 | Prediction system, prediction method, prediction device, prediction equipment and storage medium |
CN117860196B (en) * | 2023-12-05 | 2024-08-02 | 南京励翱科技有限公司 | Alzheimer disease intelligent diagnosis system, device and storage medium |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003026500A1 (en) * | 2001-09-25 | 2003-04-03 | The University Of Queensland | Method and apparatus for diagnosing schizophrenia and schizophrenia subtype |
WO2007130542A2 (en) * | 2006-05-03 | 2007-11-15 | Siemens Medical Solutions Usa, Inc. | Classification of candidates using their correlation information in computer aided diagnosis |
JP2008206830A (en) * | 2007-02-27 | 2008-09-11 | Tokyo Univ Of Science | Schizophrenia diagnosis apparatus and program |
WO2010112771A1 (en) * | 2009-04-01 | 2010-10-07 | E(Ye)Brain | Method and system for demonstrating oculomotor abnormalities |
WO2013166025A1 (en) * | 2012-05-01 | 2013-11-07 | RightEye, LLC | Systems and methods for evaluating human eye tracking |
WO2014159498A2 (en) * | 2013-03-14 | 2014-10-02 | Virginia Commonwealth University | Automated analysis system for the detection and screening of neurological disorders and deficits |
WO2015095930A1 (en) * | 2013-12-23 | 2015-07-02 | Stephanie Fryar-Williams | Mental illness model and mental illness risk assessment test for schizophrenic psychosis |
WO2016112690A1 (en) * | 2015-01-14 | 2016-07-21 | 北京工业大学 | Eye movement data based online user state recognition method and device |
JP2016163166A (en) * | 2015-03-02 | 2016-09-05 | 株式会社リコー | Communication terminal, interview system, display method and program |
CN109223006A (en) * | 2018-10-26 | 2019-01-18 | 首都医科大学附属北京安定医院 | A kind of schizophrenia diagnosis system |
CN109359403A (en) * | 2018-10-29 | 2019-02-19 | 上海市同济医院 | A kind of schizophrenia early diagnosis model and its application based on Facial expression identification magnetic resonance imaging |
CN109480865A (en) * | 2018-10-26 | 2019-03-19 | 首都医科大学附属北京安定医院 | Schizoid system is diagnosed using eye movement index |
WO2019111165A1 (en) * | 2017-12-05 | 2019-06-13 | Lam Yuen Lee Viola | Interactive and adaptive learning, neurocognitive disorder diagnosis, and noncompliance detection systems using pupillary response and face tracking and emotion detection with associated methods |
WO2020070318A1 (en) * | 2018-10-05 | 2020-04-09 | F. Hoffmann-La Roche Ag | Digital biomarkers for assessing schizophrenia |
WO2020253886A1 (en) * | 2019-06-18 | 2020-12-24 | 广州智睿医疗科技有限公司 | Supplementary diagnosis method for pathology |
CN112168187A (en) * | 2020-09-29 | 2021-01-05 | 首都医科大学附属北京安定医院 | A diagnostic index, diagnostic model and diagnostic system for schizophrenia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10013638B2 (en) * | 2008-08-14 | 2018-07-03 | Ping Zhang | Cancer diagnostic method and system |
GB201200122D0 (en) * | 2012-01-05 | 2012-02-15 | Univ Aberdeen | An apparatus and a method for psychiatric evaluation |
WO2015164807A1 (en) * | 2014-04-25 | 2015-10-29 | Texas State University | Detection of brain injury and subject state with eye movement biometrics |
-
2021
- 2021-01-20 CN CN202110075057.8A patent/CN112869744B/en active Active
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003026500A1 (en) * | 2001-09-25 | 2003-04-03 | The University Of Queensland | Method and apparatus for diagnosing schizophrenia and schizophrenia subtype |
WO2007130542A2 (en) * | 2006-05-03 | 2007-11-15 | Siemens Medical Solutions Usa, Inc. | Classification of candidates using their correlation information in computer aided diagnosis |
JP2008206830A (en) * | 2007-02-27 | 2008-09-11 | Tokyo Univ Of Science | Schizophrenia diagnosis apparatus and program |
WO2010112771A1 (en) * | 2009-04-01 | 2010-10-07 | E(Ye)Brain | Method and system for demonstrating oculomotor abnormalities |
WO2013166025A1 (en) * | 2012-05-01 | 2013-11-07 | RightEye, LLC | Systems and methods for evaluating human eye tracking |
WO2014159498A2 (en) * | 2013-03-14 | 2014-10-02 | Virginia Commonwealth University | Automated analysis system for the detection and screening of neurological disorders and deficits |
WO2015095930A1 (en) * | 2013-12-23 | 2015-07-02 | Stephanie Fryar-Williams | Mental illness model and mental illness risk assessment test for schizophrenic psychosis |
WO2016112690A1 (en) * | 2015-01-14 | 2016-07-21 | 北京工业大学 | Eye movement data based online user state recognition method and device |
JP2016163166A (en) * | 2015-03-02 | 2016-09-05 | 株式会社リコー | Communication terminal, interview system, display method and program |
WO2019111165A1 (en) * | 2017-12-05 | 2019-06-13 | Lam Yuen Lee Viola | Interactive and adaptive learning, neurocognitive disorder diagnosis, and noncompliance detection systems using pupillary response and face tracking and emotion detection with associated methods |
WO2020070318A1 (en) * | 2018-10-05 | 2020-04-09 | F. Hoffmann-La Roche Ag | Digital biomarkers for assessing schizophrenia |
CN109223006A (en) * | 2018-10-26 | 2019-01-18 | 首都医科大学附属北京安定医院 | A kind of schizophrenia diagnosis system |
CN109480865A (en) * | 2018-10-26 | 2019-03-19 | 首都医科大学附属北京安定医院 | Schizoid system is diagnosed using eye movement index |
CN109359403A (en) * | 2018-10-29 | 2019-02-19 | 上海市同济医院 | A kind of schizophrenia early diagnosis model and its application based on Facial expression identification magnetic resonance imaging |
WO2020253886A1 (en) * | 2019-06-18 | 2020-12-24 | 广州智睿医疗科技有限公司 | Supplementary diagnosis method for pathology |
CN112168187A (en) * | 2020-09-29 | 2021-01-05 | 首都医科大学附属北京安定医院 | A diagnostic index, diagnostic model and diagnostic system for schizophrenia |
Non-Patent Citations (5)
Title |
---|
支持向量机在脑电信号分类中的应用;李钢;王蔚;张胜;;计算机应用;20060610(06);第197-199+202页 * |
李瑜.首发精神分裂症与抑郁发作的眼动特征及诊断鉴别模型建立.《中国优秀硕士学位论文全文数据库(医药卫生科技辑)》.2019,正文第2-3章,图3-15. * |
精神分裂症的眼球跳视研究;李瑜;王俊杰;张天宏;王继军;;国际精神病学杂志;20170425(02);第9-11+15页 * |
首发未治疗精神分裂症患者视觉引导眼跳中速度非对称与眼跳幅度相关性研究;王晨;王克永;谢新晖;朱春燕;张蕾;孔晓明;;安徽医科大学学报;20160606(07);第109-112页 * |
首发精神分裂症与抑郁发作的眼动特征及诊断鉴别模型建立;李瑜;《中国优秀硕士学位论文全文数据库(医药卫生科技辑)》;正文第2-3章,图3-15 * |
Also Published As
Publication number | Publication date |
---|---|
CN112869744A (en) | 2021-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108937972A (en) | A kind of medical user emotion monitoring method of multiple features fusion | |
SrinivasVellela et al. | Fusion-Infused Hypnocare: Unveiling Real-Time Instantaneous Heart Rates for Remote Diagnosis of Sleep Apnea | |
CN113052113B (en) | A method and system for depression recognition based on compact convolutional neural network | |
US20180184960A1 (en) | Method and system for monitoring stress conditions | |
CN108922629A (en) | The screening and its application of brain function corelation behaviour normal form index | |
CN112869744B (en) | Auxiliary diagnosis method, system and storage medium for schizophrenia | |
Dehzangi et al. | Portable Brain‐Computer Interface for the Intensive Care Unit Patient Communication Using Subject‐Dependent SSVEP Identification | |
US20240203592A1 (en) | Content providing method, system and computer program for performing adaptable diagnosis and treatment for mental health | |
WO2023097780A1 (en) | Classification method and device for classifying patient‑ventilator asynchrony phenomenon in mechanical ventilation process | |
Gupta | StrokeSave: a novel, high-performance mobile application for stroke diagnosis using deep learning and computer vision | |
Shen et al. | Explainable depression recognition from EEG signals via graph convolutional network | |
CN211862821U (en) | A deep learning-based auxiliary assessment system for autism | |
Huang et al. | Virtual reality for training and fitness assessments for construction safety | |
Lee et al. | Artificial intelligence and machine learning in disorders of consciousness | |
CN119380969A (en) | A safe diagnostic method for medical monitoring | |
CN114424941A (en) | Fatigue detection model construction method, fatigue detection method, device and equipment | |
CN118787372A (en) | Method, device, electronic device and computer storage medium for determining epileptic discharge | |
Li et al. | Assessment of firefighter-training effectiveness in China based on human-factor parameters and machine learning | |
JP2023526412A (en) | Information processing method, electronic device, and computer storage medium | |
CN110427848B (en) | Mental analysis system | |
CN113053514A (en) | Integrated system of wisdom city doctor based on 5G communication technology | |
Wang et al. | Application of combined brain computer interface and eye tracking | |
CN115831345A (en) | Model building method and system for auxiliary diagnosis and screening of mental disorder diseases | |
Marshad et al. | Optimizing Maternal Mental Health: A Study on Boosting Algorithms for Suicidal Tendencies Prediction in Postpartum Depression | |
CN115444422A (en) | Eye movement data-based real environment psychological load assessment method and system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |